The High Proportion of Painless Thyroiditis as a Cause of Thyrotoxicosis in Korea

다국어 초록 (Multilingual Abstract)

Background and Objectives: The most common cause of thyrotoxicosis is Graves’ disease (GD), while painless thyroiditis (PT) comes in second. In Korea, the treatment of choice for GD is antithyroid drugs (ATDs). Since most cases of PT spontaneously improve, an accurate diagnosis is very important for the proper management of patients presenting with thyrotoxicosis. Materials and Methods: Ninety-nine thyrotoxic patients were routinely checked with 99m Technetium (99mTc) thyroid scan except in pregnant or lactating women. We assessed the patients’ clinical characteristics, serum levels of free T4 (FT4), thyroid stimulating hormone (TSH), thyroid peroxidase antibody (TPOAb), thyroglobulin antibody (TGAb), thyrotropin-binding inhibitory immunoglobulin (TBII), and findings of 99mTc thyroid scan. Results: Among the 99 thyrotoxic patients, 69 were diagnosed with GD and 30 had PT. All of the patients with GD, diagnosed by scan, improved clinically and the thyroid hormone returned to normal with ATDs. All patients with PT improved spontaneously without ATDs. TPOAb and TGAb were positive in 13 (43.3%) and 20 (66.7%) patients with PT, respectively. TPOAb and TGAb were positive in 45 (65.2%) and 44 (63.8%) patients with GD, respectively. TBII was positive in only 73.5% of GD, and was entirely negative in the PT group. Mean FT4 level in GD was higher than in PT, but some patients with PT showed the highest level of FT4. Conclusion: PT accounted for a very high proportion of thyrotoxicosis in this study. All parameters investigated such as age, sex, goiter size or nature, level of FT4, TPOAb or TGAb, and TBII were unable to differentiate GD from PT. Considering the increased proportion of PT in the current study, we recommend routine thyroid scan in all thyrotoxic patients except in pregnant or lactating women.

참고문헌 (Reference)

1 이상민, "갑상선중독증에서 그레이브스병과 무통성 갑상선염 감별을 위한 총 T3/유리 T4 비의 유용성" 대한내분비학회 27 (27): 121-125, 2012

2 Pearce EN, "Thyroiditis" 348 (348): 2646-2655, 2003

3 Sucupira MS, "The role of 99mTc pertechnetate uptake in the evaluation of thyroid function" 10 (10): 29-33, 1983

4 Morita T, "The occurrence of thyrotropin binding-inhibiting immunoglobulins and thyroid-stimulating antibodies in patients with silent thyroiditis" 71 (71): 1051-1055, 1990

5 Kamijo K, "TSH-receptor antibody measurement in patients with various thyrotoxicosis and Hashimoto's thyroiditis: a comparison of two two-step assays, coated plate ELISA using porcine TSH-receptor and coated tube radioassay using human recombinant TSH-receptor" 50 (50): 113-116, 2003

6 Pedersen IB, "TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays" 55 (55): 381-390, 2001

7 Iitaka M, "Stimulation of thyroid-stimulating hormone (TSH) receptor antibody production following painless thyroiditis" 60 (60): 49-53, 2004

8 Hays MT, "Simultaneous measurement of thyroidal trapping (99mTcO4-) and binding (131I-): clinical and experimental studies in man" 14 (14): 785-792, 1973

9 Schneider PB, "Simple, rapid thyroid function testing with 99mTc-pertechnetate thyroid uptake ratio and neck/thigh ratio" 132 (132): 249-253, 1979

10 Amino N, "Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves'disease and destruction-induced thyrotoxicosis" 53 (53): 113-116, 1981

11 Hollowell JG, "Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994):National Health and Nutrition Examination Survey (NHANES III)" 87 (87): 489-499, 2002

12 Costagliola S, "Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease" 84 (84): 90-97, 1999

13 Atkins HL, "Measurement of thyroidal technetium uptake with the gamma camera and computer system" 118 (118): 831-835, 1973

14 Nikolai TF, "Lymphocytic thyroiditis with spontaneously resolving hyperthyroidism and subacute thyroiditis. Long-term follow-up" 141 (141): 1455-1458, 1981

15 Shigemasa C, "Lower serum free thyroxine (T4) levels in painless thyroiditis compared with Graves' disease despite similar serum total T4 levels" 65 (65): 359-363, 1987

16 Schorr AB, "Low incidence of painless thyroiditis in the Philadelphia area" 11 (11): 379-380, 1986

17 Schwartz F, "Incidence rate of symptomatic painless thyroiditis presenting with thyrotoxicosis in Denmark as evaluated by consecutive thyroid scintigraphies" 73 (73): 240-244, 2013

18 Laurberg P, "Environmental iodine intake affects the type of nonmalignant thyroid disease" 11 (11): 457-469, 2001

19 Paunkovic J, "Does autoantibody-negative Graves'disease exist? A second evaluation of the clinical diagnosis" 38 (38): 53-56, 2006

20 Schott M, "Detecting TSH-receptor antibodies with the recombinant TBII assay: technical and clinical evaluation" 32 (32): 429-435, 2000

21 Cho BY, "Clinical thyroidology" Medical Book Publishing Company 305-375, 2010

22 Ponto KA, "Autoimmune thyrotoxicosis: diagnostic challenges" 125 (125): S1-, 2012

23 Williams I, "Aetiology of hyperthyroidism in Canada and Wales" 37 (37): 245-248, 1983

24 Hurley PJ, "A computerized system for rapid evaluation of thyroid function" 34 (34): 354-360, 1972

25 Higgins HP, "20-Min 99mTc thyroid uptake: a simplified method using the gamma camera" 14 (14): 907-911, 1973